Investors

Shareholder information

Information for our shareholders, including significant shareholdings and advisors

Shareholder Information

Corporate Goverance

How we comply with the QCA code

Corporate Governance
Circles_e-therapeutics_AR18.png

Results, Reports and Presentations

View our latest releases

Latest reports
Circles_e-therapeutics_AR18.png

AIM Rule 26

Details required under Aim rule 26

AIM Rule 26

RNS alerts

05 Mar 2019 Final Results
20 Feb 2019 Notice of Results

Email alerts

Partnering & Collaboration

Our NDD approach consistently generates potent and novel hits, assisting companies increase the productivity of their drug discovery.

Please get in touch at bd@etherapeutics.co.uk.